Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol

High blood pressure is the leading cause of preventable morbidity and mortality globally. Many patients remain on single-drug treatment with poor control, although guidelines recognize that most require combination therapy for blood pressure control. Our hypothesis is that a single-pill combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Clara K., Atkins, Emily R., Billot, Laurent, Chalmers, John, Hillis, Graham S., Hay, Peter, Neal, Bruce, Nelson, Mark, Patel, Anushka, Reid, Christopher M., Schlaich, Markus, Usherwood, Tim, Webster, Ruth, Rodgers, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531985/
https://www.ncbi.nlm.nih.gov/pubmed/33017580
http://dx.doi.org/10.1016/j.ahj.2020.09.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531985/
https://www.ncbi.nlm.nih.gov/pubmed/33017580
http://dx.doi.org/10.1016/j.ahj.2020.09.017

Ejemplares similares